Ikarian Capital »

Tarsus Pharmaceuticals shares owned by Ikarian Capital

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 619k 20.25
2023-09-30 $9.2M 519k 17.77

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Tarsus Pharmaceuticals

Cormorant Asset Management
Tang Capital Management
Cowen And Company
Frazier Life Sciences Management
Vanguard Group
Jennison Associates
Perceptive Advisors
Paradigm Biocapital Advisors
Polygon Management
Ikarian Capital
Vivo Capital
Dimensional Fund Advisors
Artisan Partners Limited Partnership
Nantahala Capital Management
Bank of America Corporation

View all funds holding Tarsus Pharmaceuticals